Effect of step-down heating on the cytotoxicity of adriamycin, bleomycin, and cis-diamminedichloroplatinum.
The cytotoxicity of a number of anticancer drugs can be potentiated by mild hyperthermia. Since the cytotoxicity of low-hyperthermic temperatures in the range of 39-43 degrees can be potentiated by using a step-down heating (SDH) sequence (short times at greater than or equal to 45 degrees followed by longer times at lower temperatures), we investigated the combined effects of SDH (specifically 45 degrees, 10 min, followed by time at 41.5 degrees) and three chemotherapeutic drugs known to be more toxic at elevated temperatures. In agreement with previous observations with Chinese hamster cells, we found that cultured RIF tumor cells showed an increased rate of cell killing at 41.5 degrees when the low-temperature heat treatment was preceded by an acute heat shock of 10 min, 45 degrees. Similarly, RIF cells showed enhanced cytotoxicity of Adriamycin, bleomycin, and cisplatin at 41.5 degrees over that at 37 degrees, as reported previously for hamster cells. When SDH and drug exposures were combined, the rate of cell killing was greater than that observed with the drugs at a constant 41.5 degrees. SDH alone reduced the Do on the 41.5 degrees survival curve from approximately 500 min to 100 min after 10 min at 45 degrees. Adriamycin cytotoxicity (0.3 microgram/ml) at 41.5 degrees was characterized by a Do of approximately 160 min for treatment times of 1 to 4 hr; with SDH, this was reduced to 52 min. Similarly, bleomycin (5 micrograms/ml) and cisplatin (0.5 microgram/ml) showed a decrease in Do by factors of 1.4 (68 to 48 min) and 2 (25.2 to 13.5 min), respectively, with the SDH sequence when compared with drug toxicity at 41.5 degrees alone. However, the sensitization to cisplatin was the same when 10 min at 45 degrees was followed by drug exposure at 37 degrees, or at 41.5 degrees. The results indicate that Adriamycin and bleomycin, but not cisplatin, cytotoxicity was increased by SDH over that achievable with 41.5 degrees alone. Possible clinical implications are discussed briefly.
D000818:Animals; D001761:Bleomycin / Q000633:toxicity*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002945:Cisplatin / Q000633:toxicity*; D004317:Doxorubicin / Q000633:toxicity*; D006358:Hot Temperature; D007700:Kinetics; D051379:Mice; D009374:Neoplasms, Experimental
D001761:Bleomycin; D004317:Doxorubicin; D002945:Cisplatin